Atlantic Union Bankshares’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.4M Sell
139,519
-37,295
-21% -$5.22M 0.37% 65
2025
Q4
$21.7M Buy
176,814
+169
+0.1% +$20.5K 0.41% 59
2025
Q3
$19.6M Sell
176,645
-7,137
-4% -$811K 0.37% 64
2025
Q2
$20.4M Buy
183,782
+8,300
+5% +$883K 0.47% 52
2025
Q1
$19.7M Buy
175,482
+67,785
+63% +$6.99M 1.19% 16
2024
Q4
$9.95M Buy
107,697
+2,110
+2% +$190K 0.58% 46
2024
Q3
$8.85M Sell
105,587
-2,789
-3% -$213K 0.51% 57
2024
Q2
$7.44M Buy
108,376
+16,311
+18% +$1.09M 0.46% 61
2024
Q1
$6.74M Buy
92,065
+5,791
+7% +$445K 0.57% 49
2023
Q4
$6.99M Buy
86,274
+2,526
+3% +$197K 0.65% 40
2023
Q3
$6.28M Buy
83,748
+1,213
+1% +$93.3K 0.64% 38
2023
Q2
$6.36M Buy
82,535
+71,339
+637% +$5.69M 0.63% 43
2023
Q1
$929K Buy
11,196
+5,654
+102% +$468K 0.1% 141
2022
Q4
$476K Hold
5,542
0.05% 183
2022
Q3
$342K Hold
5,542
0.04% 194
2022
Q2
$342K Hold
5,542
0.04% 202
2022
Q1
$329K Sell
5,542
-1,104
-17% -$70.6K 0.03% 216
2021
Q4
$482K Sell
6,646
-1,344
-17% -$92.6K 0.04% 197
2021
Q3
$558K Sell
7,990
-641
-7% -$45K 0.05% 185
2021
Q2
$595K Sell
8,631
-4,100
-32% -$274K 0.06% 186
2021
Q1
$823K Sell
12,731
-2,019
-14% -$130K 0.08% 153
2020
Q4
$860K Sell
14,750
-1,050
-7% -$63.4K 0.09% 152
2020
Q3
$998K Buy
15,800
+225
+1% +$15.6K 0.12% 131
2020
Q2
$1.2M Sell
15,575
-125
-0.8% -$9.58K 0.15% 121
2020
Q1
$1.17M Buy
15,700
+2,844
+22% +$197K 0.17% 115
2019
Q4
$835K Sell
12,856
-669
-5% -$43.6K 0.11% 150
2019
Q3
$857K Sell
13,525
-670
-5% -$43.8K 0.11% 146
2019
Q2
$959K Buy
+14,195
New +$934K 0.13% 143
2018
Q4
Sell
-2,991
Closed -$231K 131
2018
Q3
$231K Sell
2,991
-297
-9% -$22.4K 0.07% 119
2018
Q2
$233K Buy
3,288
+139
+4% +$9.82K 0.08% 115
2018
Q1
$238K Sell
3,149
-155
-5% -$12.3K 0.07% 118
2017
Q4
$236K Sell
3,304
-575
-15% -$43.7K 0.07% 122
2017
Q3
$314K Sell
3,879
-2,355
-38% -$180K 0.11% 112
2017
Q2
$441 Buy
6,234
+260
+4% +$17.3K 0.15% 94
2017
Q1
$405 Sell
5,974
-125
-2% -$8.79K 0.14% 97
2016
Q4
$437K Sell
6,099
-50
-0.8% -$3.72K 0.16% 99
2016
Q3
$486K Hold
6,149
0.19% 92
2016
Q2
$512K Buy
6,149
+192
+3% +$17K 0.2% 90
2016
Q1
$547K Sell
5,957
-220
-4% -$19.8K 0.23% 87
2015
Q4
$625K Sell
6,177
-90
-1% -$9.37K 0.27% 82
2015
Q3
$616K Buy
6,267
+102
+2% +$11.3K 0.29% 81
2015
Q2
$721K Sell
6,165
-220
-3% -$24K 0.34% 75
2015
Q1
$626K Sell
6,385
-10
-0.2% -$1.01K 0.29% 84
2014
Q4
$603K Sell
6,395
-90
-1% -$9.31K 0.27% 83
2014
Q3
$690K Sell
6,485
-20
-0.3% -$1.96K 0.32% 80
2014
Q2
$540K Hold
6,505
0.25% 91
2014
Q1
$461K Buy
+6,505
New +$510K 0.21% 95

Other funds holding GILD

Atlantic Union Bankshares's GILD Position: Q1 2026 in Review

Atlantic Union Bankshares reduced its Gilead Sciences (GILD) stake by 21% in Q1 2026, selling an estimated $5.22M and leaving 139,519 shares worth $19.4M. The position accounts for 0.37% of the portfolio, ranked #65.

Atlantic Union Bankshares first reported a position in GILD in Q1 2014 and has held it in 47 quarters since. The position peaked at $21.7M in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Atlantic Union Bankshares held 139,519 shares of Gilead Sciences worth $19.4M as of Q1 2026.
  • Atlantic Union Bankshares sold 37,295 Gilead Sciences shares in Q1 2026, an estimated $5.22M.
  • Gilead Sciences made up 0.37% of Atlantic Union Bankshares's portfolio in Q1 2026, its #65 holding.
  • Atlantic Union Bankshares first reported a position in Gilead Sciences in Q1 2014 and has held it in 47 quarters since.
  • Atlantic Union Bankshares's Gilead Sciences position peaked at $21.7M in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Atlantic Union Bankshares's 13F filing for Q1 2026, filed 12 May 2026.